药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dobutamine
Ubidecarenone
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ubidecarenone.
Dobutamine
Ipecac
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ipecac.
Dobutamine
Fusidic acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Fusidic acid.
Dobutamine
Bezafibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Bezafibrate.
Dobutamine
Isotretinoin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Dexamethasone.
Dobutamine
Fenofibric acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Fenofibric acid.
Dobutamine
Clofibride
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Clofibride.
Dobutamine
Aluminium clofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Aluminium clofibrate.
Dobutamine
Ronifibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ronifibrate.
Dobutamine
Simfibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Simfibrate.
Dobutamine
Emetine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Emetine.
Dobutamine
Mebeverine
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Mebeverine.
Dobutamine
Ciprofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ciprofibrate.
Dobutamine
Acipimox
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Acipimox.
Dobutamine
Etofibrate
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Etofibrate.
Dobutamine
Raltegravir
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Raltegravir.
Dobutamine
Mevastatin
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Mevastatin.
Dobutamine
Risedronic acid
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Dexamethasone.
Dobutamine
Metreleptin
The metabolism of Dexamethasone can be increased when combined with Metreleptin.
Dobutamine
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Dexamethasone.